Dr Dave Olim, MD | |
1440 Joel Dr, Ambler, PA 19002-3908 | |
(215) 646-1221 | |
Not Available |
Full Name | Dr Dave Olim |
---|---|
Gender | Male |
Speciality | Dermatology |
Location | 1440 Joel Dr, Ambler, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174811509 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD007774E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Dave Olim, MD 1440 Joel Dr, Ambler, PA 19002-3908 Ph: (215) 646-1221 | Dr Dave Olim, MD 1440 Joel Dr, Ambler, PA 19002-3908 Ph: (215) 646-1221 |
News Archive
Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented for the first time today at ESC Congress by principal investigator Dr Bernard De Bruyne (Belgium).
Almost 90 percent of college students who were daily smokers and 50 percent of occasional smokers were still smoking four years later, according to a study conducted at the University of Wisconsin-Madison and just published in the current issue of Health Psychology.
Medtronic today announced the first use in Latin America of renal denervation with the Medtronic Symplicity Catheter Systemâ„¢ to treat a patient with resistant hypertension, which is defined as high blood pressure despite treatment with three or more anti-hypertensive medications. Hypertension is an especially dangerous disease affecting hundreds of millions of people worldwide.
Active surveillance (AS) has become an increasingly important alternative to surgery, chemotherapy, or radiation treatment for men diagnosed with low risk prostate cancer.
› Verified 3 days ago